E0 ConsensusModerate confidencePEM not requiredSystematic-ReviewPeer-reviewedReviewed
Somatic comorbidities of irritable bowel syndrome: a systematic analysis.
Riedl, Andrea, Schmidtmann, Marco, Stengel, Andreas et al. · Journal of psychosomatic research · 2008 · DOI
Quick Summary
This study looked at other health conditions that commonly occur alongside irritable bowel syndrome (IBS). Researchers found that people with IBS are twice as likely to have other physical health problems compared to people without IBS. Conditions like fibromyalgia, chronic fatigue syndrome, and chronic pelvic pain appear in up to 65% of IBS patients, and digestive problems occur in about half of them.
Why It Matters
This study is highly relevant to ME/CFS research because chronic fatigue syndrome is specifically identified as a major extraintestinal comorbidity in IBS (appearing in up to 65% of patients), suggesting significant overlap between these conditions. Understanding shared pathophysiological mechanisms between IBS and ME/CFS could inform treatment approaches and help identify patient subgroups with specific therapeutic needs.
Observed Findings
- IBS patients show a twofold increase in somatic comorbidities compared to controls.
- Gastrointestinal comorbidities (functional dyspepsia, GERD, functional constipation, anal incontinence) occur in approximately 50% of IBS patients.
- Extraintestinal comorbidities including fibromyalgia, chronic fatigue syndrome, and chronic pelvic pain appear in up to 65% of IBS patients.
- Presence of comorbidities correlates with increased medical help-seeking, worse prognosis, and higher rates of anxiety and depression.
Inferred Conclusions
- Multiple somatic comorbidities may share common pathophysiological mechanisms with IBS, though no unified mechanism has been definitively identified.
- Structured assessment of comorbid somatic symptoms could help identify distinct IBS patient subgroups requiring tailored therapeutic approaches.
- Comorbidity burden significantly impacts quality of life and treatment outcomes in IBS patients.
Remaining Questions
- What are the specific shared pathophysiological mechanisms underlying IBS and its somatic comorbidities?
- Do different IBS patient subgroups with distinct comorbidity patterns respond differently to specific treatments?
- Can identification of comorbidity patterns improve prognostic accuracy and therapeutic outcomes in IBS?
What This Study Does Not Prove
This systematic review does not establish causation or unified pathophysiology—only documented associations between conditions. The study cannot determine whether comorbidities arise from a common biological mechanism, result from overlapping symptom reporting, or are genuinely distinct conditions occurring together. It also does not prove that treating one condition will resolve the others.
Tags
Symptom:PainFatigue
Method Flag:PEM Not DefinedWeak Case Definition
Metadata
- DOI
- 10.1016/j.jpsychores.2008.02.021
- PMID
- 18501257
- Review status
- Editor reviewed
- Evidence level
- Higher-level evidence type — systematic reviews, meta-analyses, guidelines, or major syntheses (study type, not a quality guarantee)
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.